Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
2018 · Cancer Cell · 923 citations
https://doi.org/10.1016/j.ccell.2018.03.017
J
Jennifer Tsoi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
6.5K
Citations
20
h-index
28
i10-index
Jennifer Tsoi is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 20, co-authored 90 publications.
ORCID: 0000-0001-7269-5161Papers by this author
worksGenetic Mechanisms of Immune Evasion in Colorectal Cancer
2018 · Cancer Discovery · 534 citations
https://doi.org/10.1158/2159-8290.cd-17-1327
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
2020 · Cancer Cell · 361 citations
https://doi.org/10.1016/j.ccell.2020.08.005
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
2020 · Nature Communications · 94 citations
https://doi.org/10.1038/s41467-019-12901-3
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition
2015 · BMC Cancer · 52 citations
https://doi.org/10.1186/s12885-015-1377-8
CRAF R391W is a melanoma driver oncogene
2016 · Scientific Reports · 17 citations
https://doi.org/10.1038/srep27454
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat